|
|
OPPORTUNITY AD65364
Our Client: Amgen (Applied Molecular Genetics Inc) is the world's largest biotechnology and a Fortune 500 company, a global leader in biotechnology. Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing novel medicines from lab, to manufacturing plant to patient. Amgen therapeutics has changed the practice of medicine, helping millions of people in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives. Amgen Belgium was established in 1989. Now with more than 80 staff members, Amgen Belgium encompasses a wide range of business activities from clinical development to commercial operations. Approximately 3.5% of all Amgen clinical patient enrolments each year are in Belgium. Amgen Medecines available in Belgium/Luxemburg: Neupogen (filgrastim), Neulasta (pegfilgrastim) Aranesp (darbepoetin alfa) Mimpara (cinacaclet) Kepivance (palifermin), Vectibix (panitumumab) In 2007 and 2008, Amgen was named amongst the “Best Company to Work For” in Belgium, as determined by the Vlerick Management School. Based in Brussels (Belgium) Amgen is looking for a Market Access Manager within the Regulatory Affairs Department, reporting to the Corporate & Regulatory Affairs Director. Main Tasks and Responsibilities: As Market Access Manager you will take primary responsibility for local reimbursement policies for a portfolio of first-in- class and best-in-class drugs in Belgium and Luxemburg. Within a broader context you may also be involved in dealing with issues related to Corporate Communciation, Patient Advocacy and Government Affairs. You are primarily responsible for:
Profile:
![]() | MY OPPORTUNITIESSign in to view Opportunities Don't have an account? REGISTER TODAY to save and apply for opportunities through Futurestep. |